Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
150M
-
Shares change
-
-6.63M
-
Total reported value, excl. options
-
$1.44B
-
Value change
-
-$69.2M
-
Put/Call ratio
-
0.18
-
Number of buys
-
102
-
Number of sells
-
-106
-
Price
-
$9.58
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2022
268 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q3 2022.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 150M shares
of 334M outstanding shares and own 44.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14.3M shares), BlackRock Inc. (11.5M shares), PERCEPTIVE ADVISORS LLC (10.2M shares), STATE STREET CORP (9.93M shares), Avoro Capital Advisors LLC (9.02M shares), FRANKLIN RESOURCES INC (5.18M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.71M shares), PICTET ASSET MANAGEMENT SA (3.98M shares), GOLDMAN SACHS GROUP INC (2.99M shares), and Artisan Partners Limited Partnership (2.76M shares).
This table shows the top 223 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.